94 related articles for article (PubMed ID: 1606987)
1. Expression of HLA class-I antigens on renal cell carcinoma and non-transformed renal tissue.
Buszello H; Ackermann R
Eur Urol; 1992; 21(1):70-4. PubMed ID: 1606987
[TBL] [Abstract][Full Text] [Related]
2. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH
J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
[TBL] [Abstract][Full Text] [Related]
3. Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma.
Ibrahim EC; Allory Y; Commo F; Gattegno B; Callard P; Paul P
Am J Pathol; 2003 Feb; 162(2):501-8. PubMed ID: 12547708
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B
J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical studies on the expression of HLA class I antigens in renal cell carcinoma: comparison of primary and metastatic tumor tissue.
Buszello H; Ackermann R
Eur Urol; 1994; 25(2):158-63. PubMed ID: 8137858
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.
Ibrahim EC; Guerra N; Lacombe MJ; Angevin E; Chouaib S; Carosella ED; Caignard A; Paul P
Cancer Res; 2001 Sep; 61(18):6838-45. PubMed ID: 11559559
[TBL] [Abstract][Full Text] [Related]
7. Total HLA Class I Antigen Loss with the Downregulation of Antigen-Processing Machinery Components in Two Newly Established Sarcomatoid Hepatocellular Carcinoma Cell Lines.
Lei WY; Hsiung SC; Wen SH; Hsieh CH; Chen CL; Wallace CG; Chang CC; Liao SK
J Immunol Res; 2018; 2018():8363265. PubMed ID: 30648121
[TBL] [Abstract][Full Text] [Related]
8. Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue.
Sáenz-López P; Gouttefangeas C; Hennenlotter J; Concha A; Maleno I; Ruiz-Cabello F; Cózar JM; Tallada M; Stenzl A; Rammensee HG; Garrido F; Cabrera T
Tissue Antigens; 2010 Feb; 75(2):110-8. PubMed ID: 19912575
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
Romero JM; Aptsiauri N; Vazquez F; Cozar JM; Canton J; Cabrera T; Tallada M; Garrido F; Ruiz-Cabello F
Tissue Antigens; 2006 Oct; 68(4):303-10. PubMed ID: 17026465
[TBL] [Abstract][Full Text] [Related]
10. Characterization of HLA-G expression in renal cell carcinoma.
Li BL; Lin A; Zhang XJ; Zhang X; Zhang JG; Wang Q; Zhou WJ; Chen HX; Wang TJ; Yan WH
Tissue Antigens; 2009 Sep; 74(3):213-21. PubMed ID: 19531101
[TBL] [Abstract][Full Text] [Related]
11. Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding beta2-microglobulin genes.
Hsieh CH; Hsu YJ; Chang CC; Liu HC; Chuang KL; Chuang CK; Pang ST; Hasumi K; Ferrone S; Liao SK
Cancer Immunol Immunother; 2009 Mar; 58(3):395-408. PubMed ID: 18704411
[TBL] [Abstract][Full Text] [Related]
12. Expression and regulation of non-classical HLA-G in renal cell carcinoma.
Dunker K; Schlaf G; Bukur J; Altermann WW; Handke D; Seliger B
Tissue Antigens; 2008 Aug; 72(2):137-48. PubMed ID: 18721274
[TBL] [Abstract][Full Text] [Related]
13. HLA class I expression in primary and metastatic renal cell carcinoma.
Buszello H; Ackermann R
Investig Urol (Berl); 1994; 5():55-9. PubMed ID: 7719321
[No Abstract] [Full Text] [Related]
14. Expression pattern of HLA class I antigens in renal cell carcinoma and primary cell line cultures: methodological implications for immunotherapy.
Hanak L; Slaby O; Lauerova L; Kren L; Nenutil R; Michalek J
Med Sci Monit; 2009 Dec; 15(12):CR638-43. PubMed ID: 19946235
[TBL] [Abstract][Full Text] [Related]
15. Resistance to the tubulin-binding agents in renal cell carcinoma: no mutations in the class I beta-tubulin gene but changes in tubulin isotype protein expression.
Ferguson RE; Taylor C; Stanley A; Butler E; Joyce A; Harnden P; Patel PM; Selby PJ; Banks RE
Clin Cancer Res; 2005 May; 11(9):3439-45. PubMed ID: 15867246
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas.
Hoon DS; Okun E; Banez M; Irie RF; Morton DL
Cancer Res; 1991 Oct; 51(20):5687-93. PubMed ID: 1913686
[TBL] [Abstract][Full Text] [Related]
17. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
Bukur J; Rebmann V; Grosse-Wilde H; Luboldt H; Ruebben H; Drexler I; Sutter G; Huber C; Seliger B
Cancer Res; 2003 Jul; 63(14):4107-11. PubMed ID: 12874014
[TBL] [Abstract][Full Text] [Related]
18. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer.
Doyle A; Martin WJ; Funa K; Gazdar A; Carney D; Martin SE; Linnoila I; Cuttitta F; Mulshine J; Bunn P
J Exp Med; 1985 May; 161(5):1135-51. PubMed ID: 2580935
[TBL] [Abstract][Full Text] [Related]
19. HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF.
Beniers AJ; Peelen WP; Debruyne FM; Schalken JA
Int J Cancer; 1991 Jul; 48(5):709-16. PubMed ID: 1906431
[TBL] [Abstract][Full Text] [Related]
20. Weak HLA and beta 2-microglobulin expression of neuronal cell lines can be modulated by interferon.
Lampson LA; Fisher CA
Proc Natl Acad Sci U S A; 1984 Oct; 81(20):6476-80. PubMed ID: 6436814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
